Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer. It is highly aggressive due to its late ...

The global Hematopoietic Stem Cell Transplantation Market is worth USD 7 Billion as of now and expected to reach USD 15 ...

The TIME is a dynamic network composed of cancer cells, immune cells, and stromal components. During the early stages of tumorigenesis, the TIME attempts to eliminate abnormal cells through immune ...

As global markets experience a mixed performance, with major U.S. indices reaching record highs while others face declines, investors continue to navigate through a complex economic landscape. Amidst ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The TIME is a dynamic network composed of cancer cells, immune cells, and stromal components. During the early stages of tumorigenesis, the TIME ...

East Ocyon Bio Secures USD 4.2 Mn Funding to Advance Cell and Gene Therapies East Ocyon Bio, an innovative Indian cell and gene therapy (CGT) startup, has successfully closed its USD 4.2 million seed ...

East Ocyon Bio aims to reshape Indias role in the global biotech landscape, creating an ecosystem where pioneering therapies ...

Hepatocellular carcinoma (HCC) is a significant global health issue, ranking as the sixth most prevalent malignancy and the ...

US biotech Nektar Therapeutics has announced results of its Phase II proof-of-concept study of NKTR-255 as an adjuvant ...

Medigene announces KRAS G12V as first target for TCR-guided T cell engagers: Planegg, Germany Tuesday, December 10, 2024, 17:00 Hrs [IST] Medigene AG, an oncology platform company ...